identifying therapies
we have recently undertaken an aggressive initiative where we are
partnering with cancer clinicians that treat people with cancer
. with these partnerships, we can take a therapy from testing in cancer cells and mice to companion animal cancer trials, and ultimately to humans. this is known as translational research.
with translational research, we can identify and discontinue therapies that are unlikely to have a clinical benefit. this could dramatically reduce the high failure rate we are currently seeing in cancer therapies tested in people. for therapies that show promise, we can revise, refine and improve the therapeutic approach, both in the companion animal trials, and in preclinical rodent models.
revised therapies can be further tested in companion animal trials, and then moved to human clinical trials. our team can offer novel therapies that have been robustly tested and refined in preclinical trials and companion animal cancer patients.
approaching a cure
a translational approach with companion animal models represents a shift in how we develop cancer therapies, and provides an exciting opportunity to develop effective therapies in both people and pets. and the promise of this approach extends beyond cancer to other conditions.
there are several other medical conditions that show a similarity of causes between humans and companion animals, such as
osteoarthritis of the knee and hip
and some psychiatric conditions such as
obsessive-compulsive disorder
.